Tackling antibiotic resistance during the COVID-19 pandemic is a new challenge for paediatricians

Acta Paediatr. 2021 Sep;110(9):2650-2651. doi: 10.1111/apa.15988. Epub 2021 Jun 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • COVID-19*
  • Child
  • Drug Resistance, Microbial / drug effects
  • Humans
  • Latin America
  • Pandemics*
  • Pediatricians
  • Prescriptions
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related